EClinCloud Shares Practical AI Implementation: Empowering All Teams Internally and the Full Platform Externally

Source: EClinCloud. Author: EClinCloud.

EClinCloud Shares Practical AI Implementation
Centered on the topic "Company Experiences and Challenges in AI Deployment," the meeting aimed to move the industry from AI literacy to deeper awareness and ultimately to practical application, achieving effective adoption of AI technology across the industry in a pivotal year.
As the CRO Branch's third dedicated AI-themed meeting, Dr. Qin Long, Founder and CEO of EClinCloud, once again shared AI-related implementation practices.

From two perspectives—"enabling internal teams" and "enabling clients"—Dr. Qin Long introduced EClinCloud's AI exploration from proprietary algorithms to AI agents: driving efficiency gains across all internal functions, including product, R&D, medical, and commercial teams, while delivering platform-wide AI capabilities externally to support intelligent upgrades across clients' full clinical trial lifecycle.
The presentation offered industry partners a complete perspective from technology R&D to real-world scenario deployment. During the meeting, participants also held lively discussions on practical AI implementation and organizational change in clinical trials, focusing on the application prospects of intelligent tools for improving study site selection and participant recruitment efficiency, as well as practical pathways for companies advancing AI strategies.

EClinCloud will also continue to deepen the practical application of AI technology in clinical trial scenarios, using internalized capabilities to drive external value and working alongside industry peers to advance collaborative, AI-enabled development.
*This article is reposted from the WeChat Official Account CROU.
EClinCloud is a leading AI company in the clinical research industry, leveraging AI to build an integrated intelligent clinical cloud platform and endpoint assessment technologies. It provides global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient and precise digital solutions. Relying on AI predictive models and an intelligent data platform, it dynamically evaluates and helps improve the success rate of drug clinical trials, helping shorten drug and medical device R&D cycles for the benefit of patients.



